↓ Skip to main content

Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins

Overview of attention for article published in Molecular Neurobiology, August 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
99 Mendeley
Title
Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins
Published in
Molecular Neurobiology, August 2014
DOI 10.1007/s12035-014-8843-1
Pubmed ID
Authors

Patrícia Schönhofen, Liana M. de Medeiros, Ivi Juliana Bristot, Fernanda M. Lopes, Marco A. De Bastiani, Flávio Kapczinski, José Alexandre S. Crippa, Mauro Antônio A. Castro, Richard B. Parsons, Fábio Klamt

Abstract

Cannabidiol (CBD), one of the most abundant Cannabis sativa-derived compounds, has been implicated with neuroprotective effect in several human pathologies. Until now, no undesired side effects have been associated with CBD. In this study, we evaluated CBD's neuroprotective effect in terminal differentiation (mature) and during neuronal differentiation (neuronal developmental toxicity model) of the human neuroblastoma SH-SY5Y cell line. A dose-response curve was performed to establish a sublethal dose of CBD with antioxidant activity (2.5 μM). In terminally differentiated SH-SY5Y cells, incubation with 2.5 μM CBD was unable to protect cells against the neurotoxic effect of glycolaldehyde, methylglyoxal, 6-hydroxydopamine, and hydrogen peroxide (H2O2). Moreover, no difference in antioxidant potential and neurite density was observed. When SH-SY5Y cells undergoing neuronal differentiation were exposed to CBD, no differences in antioxidant potential and neurite density were observed. However, CBD potentiated the neurotoxicity induced by all redox-active drugs tested. Our data indicate that 2.5 μM of CBD, the higher dose tolerated by differentiated SH-SY5Y neuronal cells, does not provide neuroprotection for terminally differentiated cells and shows, for the first time, that exposure of CBD during neuronal differentiation could sensitize immature cells to future challenges with neurotoxins.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 98 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 17%
Student > Bachelor 15 15%
Researcher 11 11%
Student > Ph. D. Student 11 11%
Professor 8 8%
Other 15 15%
Unknown 22 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 18%
Pharmacology, Toxicology and Pharmaceutical Science 10 10%
Biochemistry, Genetics and Molecular Biology 9 9%
Medicine and Dentistry 9 9%
Neuroscience 6 6%
Other 22 22%
Unknown 25 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2020.
All research outputs
#14,198,374
of 22,759,618 outputs
Outputs from Molecular Neurobiology
#1,810
of 3,436 outputs
Outputs of similar age
#118,882
of 230,421 outputs
Outputs of similar age from Molecular Neurobiology
#18
of 33 outputs
Altmetric has tracked 22,759,618 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,436 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,421 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.